Mumbai (Maharashtra) [India], May 12 (ANI): India Ratings and Research (Ind-Ra) has said the 51.5 per cent year-on-year growth in India's pharmaceutical market during April was led by a low base effect as the market declined by 10.2 per cent in April 2020 due to Covid-19 lockdown.